Saisheng Pharmaceutical (06600) announced that on April 2, 2024, the company's initial public offering of an after-sales share purchase plan...
According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) announced that on April 2, 2024, 42,000 share options granted under the company's initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.